These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 26436831)

  • 41. Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
    Torres-Gonzalez P; Cervera-Hernandez ME; Niembro-Ortega MD; Leal-Vega F; Cruz-Hervert LP; García-García L; Galindo-Fraga A; Martinez-Gamboa A; Bobadilla-Del Valle M; Sifuentes-Osornio J; Ponce-de-Leon A
    PLoS One; 2015; 10(10):e0139883. PubMed ID: 26431402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
    Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
    J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associated factors and outcomes for OXA-232 Carbapenem-resistant Enterobacteriaceae infections in a tertiary care centre in Mexico City: A case-control-control study.
    Torres-González P; Ortiz-Brizuela E; Cervera-Hernandez ME; Bobadilla-Del Valle M; Martínez-Gamboa A; Sifuentes-Osornio J; Ponce-de-Leon A
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):243-8. PubMed ID: 27519297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.
    Mataseje LF; Abdesselam K; Vachon J; Mitchel R; Bryce E; Roscoe D; Boyd DA; Embree J; Katz K; Kibsey P; Simor AE; Taylor G; Turgeon N; Langley J; Gravel D; Amaratunga K; Mulvey MR
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6787-6794. PubMed ID: 27600052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015.
    Bulens SN; Reses HE; Ansari UA; Grass JE; Carmon C; Albrecht V; Lawsin A; McAllister G; Daniels J; Lee YK; Yi S; See I; Jacob JT; Bower CW; Wilson L; Vaeth E; Lynfield R; Vagnone PS; Shaw KM; Dumyati G; Tsay R; Phipps EC; Bamberg W; Janelle SJ; Beldavs ZG; Cassidy PM; Kainer M; Muleta D; Mounsey JT; Laufer-Halpin A; Karlsson M; Lutgring JD; Walters MS
    Am J Infect Control; 2023 Jan; 51(1):70-77. PubMed ID: 35909003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital.
    Drew RJ; Turton JF; Hill RL; Livermore DM; Woodford N; Paulus S; Cunliffe NA
    J Hosp Infect; 2013 Aug; 84(4):300-4. PubMed ID: 23831281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States.
    Guh AY; Limbago BM; Kallen AJ
    Expert Rev Anti Infect Ther; 2014 May; 12(5):565-80. PubMed ID: 24666262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival.
    Balkan II; Aygün G; Aydın S; Mutcalı SI; Kara Z; Kuşkucu M; Midilli K; Şemen V; Aras S; Yemişen M; Mete B; Özaras R; Saltoğlu N; Tabak F; Öztürk R
    Int J Infect Dis; 2014 Sep; 26():51-6. PubMed ID: 24998423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbapenem-Resistant Enterobacter cloacae in Patients from the US Veterans Health Administration, 2006-2015.
    Wilson BM; El Chakhtoura NG; Patel S; Saade E; Donskey CJ; Bonomo RA; Perez F
    Emerg Infect Dis; 2017 May; 23(5):878-880. PubMed ID: 28418318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001-2010.
    Zarfel G; Hoenigl M; Würstl B; Leitner E; Salzer HJ; Valentin T; Posch J; Krause R; Grisold AJ
    Clin Microbiol Infect; 2011 Nov; 17(11):E5-8. PubMed ID: 21939472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases--United States, 2010-2015.
    Lyman M; Walters M; Lonsway D; Rasheed K; Limbago B; Kallen A
    MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(47):1315-6. PubMed ID: 26633574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City.
    Prasad N; Labaze G; Kopacz J; Chwa S; Platis D; Pan CX; Russo D; LaBombardi VJ; Osorio G; Pollack S; Kreiswirth BN; Chen L; Urban C; Segal-Maurer S
    Am J Infect Control; 2016 May; 44(5):525-32. PubMed ID: 26796684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
    Dai W; Sun S; Yang P; Huang S; Zhang X; Zhang L
    Infect Genet Evol; 2013 Mar; 14():1-7. PubMed ID: 23220359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms - United States, 2006-2017.
    Woodworth KR; Walters MS; Weiner LM; Edwards J; Brown AC; Huang JY; Malik S; Slayton RB; Paul P; Capers C; Kainer MA; Wilde N; Shugart A; Mahon G; Kallen AJ; Patel J; McDonald LC; Srinivasan A; Craig M; Cardo DM
    MMWR Morb Mortal Wkly Rep; 2018 Apr; 67(13):396-401. PubMed ID: 29621209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
    Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
    Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular epidemiology of KPC-2-producing Enterobacteriaceae (non-Klebsiella pneumoniae) isolated from Brazil.
    Tavares CP; Pereira PS; Marques Ede A; Faria C; de Souza Mda P; de Almeida R; Alves Cde F; Asensi MD; Carvalho-Assef AP
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):326-30. PubMed ID: 25935630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.
    Teo J; Cai Y; Tang S; Lee W; Tan TY; Tan TT; Kwa AL
    PLoS One; 2012; 7(3):e34254. PubMed ID: 22461908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Notes from the Field: Verona Integron-Encoded Metallo-Beta-Lactamase-Producing Carbapenem-Resistant Enterobacteriaceae in a Neonatal and Adult Intensive Care Unit--Kentucky, 2015.
    Yaffee AQ; Roser L; Daniels K; Humbaugh K; Brawley R; Thoroughman D; Flinchum A
    MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(7):190. PubMed ID: 26914726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbapenem non-susceptible enterobacteriaceae in Quebec, Canada: results of a laboratory surveillance program (2010-2012).
    Lefebvre B; Lévesque S; Bourgault AM; Mulvey MR; Mataseje L; Boyd D; Doualla-Bell F; Tremblay C
    PLoS One; 2015; 10(4):e0125076. PubMed ID: 25910041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.